Buprenorphine - How it is used in fighting Opioid Addiction

Buprenorphine is administered in several forms, each tailored to different needs and circumstances of individuals undergoing treatment for opioid addiction. Here’s a detailed summary of the administration methods:

1. Sublingual Tablets and Films

• Method: Sublingual administration involves placing the medication under the tongue, where it dissolves and is absorbed through the mucous membranes directly into the bloodstream.

• Common Brands: Suboxone (a combination of buprenorphine and naloxone), Subutex (buprenorphine alone).

• Dosage: The dosage is typically individualized, starting with a lower dose that is gradually adjusted based on the patient’s response. Initial dosing often starts at 2 mg to 4 mg, with adjustments made according to withdrawal symptoms and cravings.

• Frequency: Usually taken once daily, though some patients might take it multiple times a day based on their specific treatment plan.

2. Buccal Film

• Method: The buccal film is placed on the inside of the cheek, where it dissolves and is absorbed through the mucous membranes.

• Common Brand: Belbuca.

• Dosage: Typically starts at 75 mcg once daily or every 12 hours, depending on the patient’s needs and response.

• Frequency: Usually administered once or twice daily.

3. Extended-Release Injection

• Method: The extended-release injectable form of buprenorphine is administered as a subcutaneous injection, typically in the abdominal area. The medication is slowly released into the bloodstream over a specified period.

• Common Brands: Sublocade.

• Dosage: Initial doses usually start at 300 mg, followed by maintenance doses of 100 mg or 300 mg monthly, depending on the patient’s treatment response.

• Frequency: Administered once a month by a healthcare provider, ensuring steady levels of medication in the body over time.

4. Implant

• Method: The buprenorphine implant involves inserting small rods under the skin of the upper arm. These rods release a controlled amount of buprenorphine over an extended period.

• Common Brand: Probuphine.

• Dosage: Each implant contains a total of 80 mg of buprenorphine, released over six months.

• Frequency: Implants are typically left in place for six months and may be replaced if long-term treatment is necessary.

5. Transdermal Patch

• Method: The buprenorphine transdermal patch is applied to the skin, where it releases medication steadily over a specific period.

• Common Brand: Butrans.

• Dosage: Available in varying strengths (e.g., 5 mcg/h, 10 mcg/h, 20 mcg/h), the appropriate dosage is determined based on patient needs.

• Frequency: Patches are typically replaced once a week.

6. Administration Considerations

• Induction Phase: For patients starting buprenorphine, the induction phase involves the initial administration of the medication under medical supervision, often in a controlled setting, to monitor for adverse effects and adjust dosage.

• Maintenance Phase: Once the appropriate dose is determined, patients enter the maintenance phase, where they continue regular use of buprenorphine to manage cravings and prevent relapse.

• Tapering and Discontinuation: If and when discontinuation of buprenorphine is considered, it is typically done through a gradual tapering of the dose to minimize withdrawal symptoms.

7. Patient Monitoring and Compliance

• Monitoring: Regular follow-ups with healthcare providers are essential to monitor the effectiveness of treatment, adjust dosages, and ensure that the patient adheres to the prescribed regimen.

• Compliance: Compliance is crucial for the success of buprenorphine treatment. Patients must take the medication as directed, and healthcare providers may conduct regular assessments or use tools like observed dosing to ensure adherence.

Buprenorphine’s various forms of administration provide flexibility in treatment, allowing healthcare providers to tailor therapy to the individual needs and circumstances of each patient. This flexibility is one of the key strengths of buprenorphine in treating opioid addiction.

Contact HWOANY at 1-888-995-3405

www.helpwithopioidaddictionnewyork.com.